Bloomberg News

Apple, Corcept Therapeutics, Codexis: U.S. Equity Preview

February 20, 2012

Feb. 17 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading on Feb. 21. U.S. markets will be closed on Feb. 20 for the Presidents’ Day holiday. Stock symbols are in parentheses, and prices are as of 5:40 p.m. in New York.

Standard & Poor’s 500 Index futures expiring in March rose 0.4 percent to 1,359.70.

Apple Inc. (AAPL US): HTC Corp. lost a patent-infringement claim against the world’s largest technology company at the U.S. International Trade Commission, the first of the Taiwanese handset maker’s cases targeting the iPhone.

Corcept Therapeutics Inc. (CORT US): The specialty drug company that hasn’t generated revenue since 2009 won approval for its leading product candidate, a treatment that uses the active ingredient of the abortion pill RU-486 to treat Cushing’s Syndrome.

Codexis Inc. (CDXS US): Alan Shaw resigned as president and chief executive officer of the company, which makes enzymes used in producing drugs. He will continue to serve as an adviser to the board of directors. The board appointed Peter Strumph, business head of pharmaceuticals, as interim CEO.

--Editor: Michael P. Regan

To contact the reporter on this story: Katia Porzecanski in New York at kporzecansk1@bloomberg.net

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus